Therapy Areas: Oncology
17 June 2019 - - US-based Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) has launched a corporate reorganisation in order to maximise the commercial opportunity for Xerava (eravacycline), the co...
17 June 2019 - Valo Therapeutics Limited, a cancer immunotherapy company developing neoantigen-coated oncolytic viruses as therapeutic vaccines, announced today that it has named Dr Michael Stein as i...
17 June 2019 - The US Food and Drug Administration (FDA) has granted approval to US-based Amgen and Ireland-based Allergan for its Kanjinti (trastuzumab-anns), a biosimilar to Roche's Herceptin (...
17 June 2019 - Cancer immunotherapy company Valo Therapeutics Limited stated on Monday that Dr Michael Stein, PhD, MD, has been elected to the full-time role of chief executive officer.Prior to the ne...
17 June 2019 - Swiss biotechnology company Elthera reported on Monday the receipt of EUR2.5m through the Horizon 2020 programme.Horizon 2020 is the financial instrument implementing the Innovation Uni...
17 June 2019 - Oncopeptides AB (STO:ONCO) on Friday announced the presentation of new data at the 24th Congress of the European Haematology Association (EHA) in Amsterdam, including updated interim da...
Related Headlines